Leonardi C - Search Results

1

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR).

Kimball AB, Leonardi C, Stahle M, Gulliver W, Chevrier M, Fakharzadeh S, Goyal K, Calabro S, Langholff W, Menter A; PSOLAR Steering Committee. Kimball AB, et al. Among authors: leonardi c. Br J Dermatol. 2014 Jul;171(1):137-47. doi: 10.1111/bjd.13013. Epub 2014 Jul 16. Br J Dermatol. 2014. PMID: 24684204 Free PMC article.

2

Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.

Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL; EFALIZUMAB STUDY GROUP. Gottlieb AB, et al. J Drugs Dermatol. 2004 Nov-Dec;3(6):614-24. J Drugs Dermatol. 2004. PMID: 15624744 Clinical Trial.

3

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

4

Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.

Gottlieb AB, Leonardi CL, Goffe BS, Ortonne JP, van der Kerkhof PC, Zitnik R, Nakanishi A, Jahreis A. Gottlieb AB, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S92-100. doi: 10.1016/j.jaad.2005.10.053. J Am Acad Dermatol. 2006. PMID: 16488335

5

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.

Gottlieb AB, Hamilton T, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Gottlieb AB, et al. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S154-63. doi: 10.1016/j.jaad.2005.12.018. J Am Acad Dermatol. 2006. PMID: 16488337 Clinical Trial.

6

Long-term management of plaque psoriasis with continuous efalizumab therapy.

Menter A, Leonardi CL, Sterry W, Bos JD, Papp KA. Menter A, et al. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S182-8. doi: 10.1016/j.jaad.2005.10.028. J Am Acad Dermatol. 2006. PMID: 16488340 Review. No abstract available.

7

Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.

Pariser DM, Gordon KB, Papp KA, Leonardi CL, Kwon P, Compton PG, Rundle AC, Walicke PA, Lebwohl M. Pariser DM, et al. J Cutan Med Surg. 2005 Dec;9(6):303-12. doi: 10.1007/s10227-005-0116-1. J Cutan Med Surg. 2005. PMID: 16699904 Review.

8

A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis.

Leonardi CL, Toth D, Cather JC, Langley RG, Werther W, Compton P, Kwon P, Wetherill G, Curtin F, Menter A. Leonardi CL, et al. Dermatology. 2006;213(3):204-14. doi: 10.1159/000095037. Dermatology. 2006. PMID: 17033169

9

On multiple courses of alefacept.

Leonardi CL, Strober BE. Leonardi CL, et al. J Am Acad Dermatol. 2006 Nov;55(5):916-7. doi: 10.1016/j.jaad.2006.04.075. J Am Acad Dermatol. 2006. PMID: 17052512 No abstract available.

10

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M, Papp K. Menter A, et al. J Am Acad Dermatol. 2008 Jan;58(1):106-15. doi: 10.1016/j.jaad.2007.09.010. Epub 2007 Oct 23. J Am Acad Dermatol. 2008. PMID: 17936411 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters